HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Rossignol Selected Research

procollagen type I carboxy terminal peptide (PICP)

6/2022Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.
1/2022The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
1/2021Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction.
1/2019Low fibrosis biomarker levels predict cardiac resynchronization therapy response.
1/2019Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Rossignol Research Topics

Disease

132Heart Failure
10/2022 - 05/2009
51Hypertension (High Blood Pressure)
01/2022 - 01/2003
40Fibrosis (Cirrhosis)
06/2022 - 07/2010
38Myocardial Infarction
04/2022 - 10/2004
27Inflammation (Inflammations)
06/2022 - 01/2010
27Chronic Renal Insufficiency
01/2022 - 10/2015
25Hyperkalemia
01/2022 - 11/2012
18Left Ventricular Dysfunction
04/2022 - 05/2009
15Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 02/2012
14Chronic Kidney Failure (Chronic Renal Failure)
03/2022 - 06/2013
11Thrombosis (Thrombus)
06/2021 - 11/2002
9Atrial Fibrillation
04/2022 - 01/2018
9Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2019
9Diabetes Mellitus
05/2021 - 01/2014
7Renal Insufficiency (Renal Failure)
01/2022 - 11/2012
7Obesity
01/2022 - 08/2015
7Hypokalemia
01/2021 - 04/2008
6Stroke (Strokes)
02/2022 - 05/2014
6Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2022 - 08/2012
6Acute Coronary Syndrome
01/2021 - 05/2014
6Hyperaldosteronism (Conn Syndrome)
01/2018 - 04/2008
5Kidney Diseases (Kidney Disease)
01/2022 - 12/2018
5Systolic Heart Failure
01/2021 - 11/2012
5Respiratory Sounds (Crackle)
01/2020 - 11/2012
4Body Weight (Weight, Body)
04/2022 - 11/2011
4Hemorrhage
02/2022 - 06/2013
4Neoplasms (Cancer)
01/2022 - 10/2004
4Hypertrophy
01/2022 - 06/2010
4Albuminuria
05/2021 - 02/2012
4Atherosclerosis
01/2019 - 10/2007
4Aneurysm (Aneurysms)
04/2011 - 11/2002
3Weight Loss (Weight Reduction)
04/2022 - 11/2017
3Isolated Systolic Hypertension
11/2021 - 04/2006
3Anemia
01/2021 - 03/2012
3Acute Kidney Injury (Acute Renal Failure)
02/2019 - 01/2016
3Aortic Valve Stenosis (Aortic Stenosis)
01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

44Biomarkers (Surrogate Marker)IBA
06/2022 - 03/2006
37Mineralocorticoid Receptor AntagonistsIBA
01/2022 - 05/2009
34PotassiumIBA
09/2021 - 11/2011
31Eplerenone (Inspra)FDA LinkGeneric
04/2022 - 05/2009
25Spironolactone (Aldactone)FDA LinkGeneric
04/2022 - 11/2012
22AldosteroneIBA
01/2020 - 04/2008
16Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2003
16Galectin 3 (LGALS3)IBA
06/2022 - 01/2012
16CollagenIBA
01/2022 - 08/2008
14Antihypertensive Agents (Antihypertensives)IBA
11/2021 - 04/2006
12SodiumIBA
04/2022 - 06/2016
12CreatinineIBA
01/2022 - 07/2014
11DiureticsIBA
04/2022 - 11/2011
9patiromerIBA
01/2022 - 01/2018
9Pharmaceutical PreparationsIBA
01/2022 - 10/2013
9Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 05/2009
9ReninIBA
01/2020 - 01/2002
8Natriuretic PeptidesIBA
01/2022 - 01/2018
8Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
06/2021 - 05/2012
7Biological ProductsIBA
06/2022 - 11/2002
7pro-brain natriuretic peptide (1-76)IBA
01/2022 - 11/2016
7procollagen Type III-N-terminal peptide (PIIP)IBA
01/2022 - 08/2008
7Collagen Type I (Type I Collagen)IBA
01/2022 - 05/2009
7Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
08/2021 - 08/2013
6Procollagen Type IIBA
06/2022 - 11/2013
6Collagen Type III (Type III Collagen)IBA
01/2022 - 11/2013
6Angiotensin Receptor AntagonistsIBA
06/2021 - 03/2015
6Matrix Metalloproteinases (MMPs)IBA
01/2021 - 05/2002
6AmberIBA
01/2021 - 01/2018
6LectinsIBA
01/2018 - 01/2013
5Peptides (Polypeptides)IBA
06/2022 - 02/2010
5procollagen type I carboxy terminal peptide (PICP)IBA
06/2022 - 01/2019
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2012
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2021 - 01/2019
5Hemoglobins (Hemoglobin)IBA
11/2020 - 02/2010
5ElectrolytesIBA
10/2020 - 11/2016
5SaltsIBA
10/2020 - 12/2011
5Phenobarbital (Luminal)FDA Link
04/2011 - 11/2002
4C-Reactive ProteinIBA
06/2022 - 08/2008
4alogliptinIBA
07/2021 - 01/2020
4AlbuminsIBA
01/2021 - 01/2018
4Insulin (Novolin)FDA Link
01/2021 - 02/2019
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2020 - 01/2002
4CholesterolIBA
01/2020 - 01/2002
4LipidsIBA
02/2019 - 01/2010
4Angiotensin IIIBA
01/2018 - 01/2002
4AngiotensinsIBA
04/2017 - 03/2012
4citrus pectinIBA
01/2016 - 01/2015
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 02/2013
3Interleukin-6 (Interleukin 6)IBA
06/2021 - 08/2012
3Losartan (Cozaar)FDA LinkGeneric
01/2021 - 03/2015
3Messenger RNA (mRNA)IBA
01/2021 - 01/2003
3Uric Acid (Urate)IBA
10/2020 - 11/2015
3Lipocalin-2IBA
01/2018 - 12/2017
3MineralocorticoidsIBA
01/2018 - 12/2011

Therapy/Procedure

41Therapeutics
01/2022 - 01/2002
12Renal Dialysis (Hemodialysis)
06/2022 - 08/2012
6Kidney Transplantation
03/2022 - 12/2017
5Renal Replacement Therapy (Therapies, Renal Replacement)
02/2022 - 05/2014
4Denervation
11/2019 - 10/2015
3Length of Stay
01/2022 - 10/2018
3Nephrectomy
01/2021 - 01/2002
3Cardiac Resynchronization Therapy
01/2019 - 01/2012
3Stents
01/2018 - 10/2001